Speaker(s): 

Paul K.J. Han, MD, MA, MPH, Senior Scientist, Division of Cancer Control and Population Sciences, National Cancer Institute - has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Provide overview of my past research on medical uncertainty, and
   lessons learned

2. Outline a provisional normative conception of “uncertainty
   tolerance”

3. Identify potential opportunities for future research

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Michelle Meyer, PhD, JD, HEC-C, F. Daniel Davis, PhD, HEC-C, Sharon Gray, MA, BSN, RN, HEC-C, Daniel J. Hoegen, MSW, LSW, HEC-C, Christopher Chabris, PhD, Greg Burke, MD, John Pagnotto, MD, Elizabeth McDonald, MS, RDN, LDN, CNSC, Linda Page, RT, Ronald Napikoski, RT, Dean Parry, RPH, Kaylee Kachurka, PA-C, Erin Hall- Melnychuk, PhD, Anne Kasper, LPC, BBC have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose: Angela Slampak-Cindric, PharmD, BCPS, Kelly Ryan Shaw, PsyD

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None